Table II. Characteristics of Study Participants in the study.

Disease	No.	Gender(M/F)	Age
Phase I
BD	40	16/14	40.0 ± 12.2
Autoimmune disease (5TA,5AAV,5SS)	15	5/10	45.0 ± 9.7
Healthy controls	20	11/9	41.5 ± 11.9
Phase II
BD	130	65/65	36.2 ± 11.3
Autoimmune disease	118	26/77	44.2 ± 18.0
TA	40	6/34	29.4 ± 8.8
AAV	40	20/20	54.9 ± 16.0
SS	23	0/23	51.2 ± 16.2
Healthy controls	110	78/32	36.9 ± 8.3